Literature DB >> 20234359

Ethnogenetic heterogeneity of rheumatoid arthritis-implications for pathogenesis.

Yuta Kochi1, Akari Suzuki, Ryo Yamada, Kazuhiko Yamamoto.   

Abstract

Autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus are generally considered multifactorial-that is, they involve both genetic and environmental factors. Technical advances in human genetics over the past 5 years have enabled the survey of the entire human genome for disease susceptibility genes and have contributed to a greater understanding of the molecular mechanisms underlying autoimmunity. Among the genetic predisposition factors identified to date, some variants have been found to be restricted to specific ethnic groups, which might reflect migration history and the natural selection that shaped genetic variation in these populations. Other genetic factors could also have exerted different magnitudes of risk for the disease among the different populations, which might be explained by their interactions with other genetic and environmental factors. These pieces of evidence suggest that substantial heterogeneity exists in the genetics underlying autoimmunity among different ethnic populations. This Review discusses the genetic heterogeneity in autoimmunity, with a focus on rheumatoid arthritis, between Asian and European populations. In addition to the most-studied and well-characterized gene HLA-DRB1, we will also describe examples of the gene-environment interactions between PADI4 and smoking, and the gene-gene interactions between PTPN22 and FCRL3.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20234359     DOI: 10.1038/nrrheum.2010.23

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  69 in total

1.  Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.

Authors:  Adrian F Arechiga; Tania Habib; Yantao He; Xian Zhang; Zhong-Yin Zhang; Andrew Funk; Jane H Buckner
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

2.  HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis.

Authors:  D L Mattey; P T Dawes; M A Gonzalez-Gay; C Garcia-Porrua; W Thomson; A H Hajeer; W E Ollier
Journal:  J Rheumatol       Date:  2001-02       Impact factor: 4.666

3.  Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis.

Authors:  K Ikari; S Momohara; T Nakamura; M Hara; H Yamanaka; T Tomatsu; N Kamatani
Journal:  Ann Rheum Dis       Date:  2005-09-21       Impact factor: 19.103

4.  A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.

Authors:  Yuta Kochi; Ryo Yamada; Akari Suzuki; John B Harley; Senji Shirasawa; Tetsuji Sawada; Sang-Cheol Bae; Shinya Tokuhiro; Xiaotian Chang; Akihiro Sekine; Atsushi Takahashi; Tatsuhiko Tsunoda; Yozo Ohnishi; Kenneth M Kaufman; Changsoo Paul Kang; Changwon Kang; Shigeru Otsubo; Wako Yumura; Akio Mimori; Takao Koike; Yusuke Nakamura; Takehiko Sasazuki; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2005-04-17       Impact factor: 38.330

5.  Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease.

Authors:  M J Simmonds; J M Heward; J Carr-Smith; H Foxall; J A Franklyn; S C L Gough
Journal:  J Clin Endocrinol Metab       Date:  2005-12-29       Impact factor: 5.958

6.  Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.

Authors:  Floris A van Gaalen; Jill van Aken; Tom W J Huizinga; Geziena M Th Schreuder; Ferdinand C Breedveld; Eric Zanelli; Walther J van Venrooij; Cornelis L Verweij; René E M Toes; René R P de Vries
Journal:  Arthritis Rheum       Date:  2004-07

7.  Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences.

Authors:  Yuta Kochi; Ryo Yamada; Kyoko Kobayashi; Atsushi Takahashi; Akari Suzuki; Akihiro Sekine; Akihiko Mabuchi; Fumihiro Akiyama; Tatsuhiko Tsunoda; Yusuke Nakamura; Kazuhiko Yamamoto
Journal:  Arthritis Rheum       Date:  2004-01

8.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Authors:  Ann B Begovich; Victoria E H Carlton; Lee A Honigberg; Steven J Schrodi; Anand P Chokkalingam; Heather C Alexander; Kristin G Ardlie; Qiqing Huang; Ashley M Smith; Jill M Spoerke; Marion T Conn; Monica Chang; Sheng-Yung P Chang; Randall K Saiki; Joseph J Catanese; Diane U Leong; Veronica E Garcia; Linda B McAllister; Douglas A Jeffery; Annette T Lee; Franak Batliwalla; Elaine Remmers; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Christopher I Amos; John J Sninsky; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

9.  HLA class 2 genes in Singaporean Chinese rheumatoid arthritis.

Authors:  S H Chan; Y N Lin; G B Wee; W H Koh; M L Boey
Journal:  Br J Rheumatol       Date:  1994-08

10.  Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide.

Authors:  T Furuya; M Hakoda; N Ichikawa; K Higami; Y Nanke; T Yago; T Kobashigawa; K Tokunaga; N Tsuchiya; N Kamatani; S Kotake
Journal:  Clin Exp Rheumatol       Date:  2007 Mar-Apr       Impact factor: 4.473

View more
  33 in total

1.  Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors.

Authors:  Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 2.  Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy?

Authors:  A M Mohamed Thoufic Ali; S Vino
Journal:  Rheumatol Int       Date:  2016-09-16       Impact factor: 2.631

3.  Cutting-edge issues in organ-specific autoimmunity.

Authors:  M Eric Gershwin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

4.  Mycobacterium tuberculosis promotes arthritis development through Toll-like receptor 2.

Authors:  Hiroya Kanagawa; Yasuo Niki; Tami Kobayashi; Yuiko Sato; Eri Katsuyama; Atsuhiro Fujie; Wu Hao; Kana Miyamoto; Toshimi Tando; Ryuichi Watanabe; Mayu Morita; Hideo Morioka; Morio Matsumoto; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  J Bone Miner Metab       Date:  2014-03-15       Impact factor: 2.626

Review 5.  TLRs, future potential therapeutic targets for RA.

Authors:  Hatem A Elshabrawy; Abdul E Essani; Zoltán Szekanecz; David A Fox; Shiva Shahrara
Journal:  Autoimmun Rev       Date:  2016-12-15       Impact factor: 9.754

6.  A functional variant in FCRL3 is associated with higher Fc receptor-like 3 expression on T cell subsets and rheumatoid arthritis disease activity.

Authors:  Urmila D Bajpai; Louise A Swainson; Jeff E Mold; Jonathan D Graf; John B Imboden; Joseph M McCune
Journal:  Arthritis Rheum       Date:  2012-08

7.  Mechanisms and pathophysiology of autoimmune disease.

Authors:  Wesley H Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

Review 8.  Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis.

Authors:  Xinqiang Song; Qingsong Lin
Journal:  Rheumatol Int       Date:  2017-05-10       Impact factor: 2.631

Review 9.  Autoimmune thyroid disease and rheumatoid arthritis: relationship and the role of genetics.

Authors:  Ivica Lazúrová; Ivana Jochmanová; Karim Benhatchi; Stefan Sotak
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

10.  Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis.

Authors:  Jeffrey D Greenberg; Tanya M Spruill; Ying Shan; George Reed; Joel M Kremer; Jeffrey Potter; Yusuf Yazici; Gbenga Ogedegbe; Leslie R Harrold
Journal:  Am J Med       Date:  2013-12       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.